A previous systematic review by Montellano et al. (2021) investigated potential biomarkers for mortality and functional prognosis in ischemic stroke patients, concluding that inflammatory biomarkers such as CRP, IL-6, and TNF-α were inconsistently associated with poor outcomes [105]. The gene discussed is IL6; the disease is ischemic stroke.